CLOSE

Benchmark Investments

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.41 0.01(0.03%) NAV as on 01 Sep 2025
-0.62 % 1 M
-1.66 % 1 Y
23.43 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.10

As on 31 Jul, 2025
Age :

9 yrs 8 m

Since 28 12 ,2015
Exit Load :

0.25%

AUM :

1,339.00 Crs

Portfolio Price To Book Value :

7.49

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Rajat Srivastava

Launch Date :

28-Dec-15

Scheme Benchmark :

NA

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jul 31 ,2025
Others 6.22 %
Equity 93.78 %

TOP HOLDINGS

Sun Pharmaceutical Industries...10.92 %
Cipla Ltd.6.62 %
Apollo Hospitals Enterprise Ltd.5.20 %
Lupin Ltd.4.77 %
Healthcare Global Enterprises...4.38 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs55.01
Hospital & Healthcare Services33.71
Business Support2.55
Insurance1.63
Retailing0.83
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)14.7317.1815.8825.0628.64
Net Assets(Rs Crores) (as on 31-Mar-2025) 435.03 553.33 493.44 878.70 1183.65
Scheme Returns(%)(Absolute)67.2416.04-7.3157.4613.01
B'mark Returns(%)(Absolute)NANANANANA
Category Rank49/7541/7567/7619/9020/102

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20265.44NANANA
2024-20254.6218.851.96-9.86
2023-202415.1911.1111.3810.75
2022-2023-10.368.14-0.52-4.19
2021-202216.843.710.97-4.64

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.410.01(0.03%)NAV As on 01 Sep, 202528-Dec-2015Inception Date1,339.00AUM In Cr.-1.66%1Y23.43%3Y18.92%5Y12.17%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.660.03(0.08%)NAV As on 01 Sep, 202513-Jul-2018Inception Date6,103.96AUM In Cr.3.71%1Y28.18%3Y21.45%5Y21.28%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity428.771.33(0.31%)NAV As on 01 Sep, 202514-Jul-1999Inception Date4,026.55AUM In Cr.5.02%1Y26.17%3Y20.75%5Y16.18%Since Inception
Nippon India Pharma Fund(G)Very HighEquity509.161.11(0.22%)NAV As on 01 Sep, 202505-Jun-2004Inception Date8,736.57AUM In Cr.-1.85%1Y22.78%3Y18.75%5Y20.31%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd